ROYAL BANK OF CANADA

Bank

Position in TAK — Takeda Pharmaceutical Co Ltd

CIK 1000275 TORONTO, A6

Back to TAK Full portfolio

Position in TAK

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$11,387,039

+$2,748,219 QoQ

Shares Held

614,851

+11.0% QoQ

Ownership

0.019%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 61.81644008060489.ToString("F0")% Shared 37.76768680542115.ToString("F0")% None 0.4158731139739547.ToString("F0")%

Common Shares in TAK Over Time

Shares Held

Position Value (USD)

Derivatives in TAK

reported options exposure · as of Jun 30, 2023

CallValue

$15,177,431

CallShares

966,100

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

ROYAL BANK OF CANADA holds $672,208,369 across 64 Drug Manufacturers - Specialty & Generic names. TAK ranks #10 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	1,974,284	$233,380,104
2	RDY	Dr Reddys Laboratories Ltd	9,984,082	$138,279,533
3	BHC	Bausch Health Companies Inc.	11,363,498	$61,362,887
4	NBIX	Neurocrine Biosciences Inc	332,300	$43,777,199
5	VTRS	Viatris Inc	2,907,645	$39,282,278
6	UTHR	UNITED THERAPEUTICS Corp	59,152	$35,075,949
7	HLN	Haleon plc	3,063,916	$30,669,795
8	TEVA	Teva Pharmaceutical Industries Ltd	963,824	$29,030,375

All Filings in TAK

Export CSV

33 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$11,387,039	614,851	+11.0%	Shares	Defined	2026-05-15
2025-12-31	$8,638,820	554,126	+13.2%	Shares	Defined	2026-02-17
2025-09-30	$7,164,724	489,394	+5.3%	Shares	Defined	2025-11-14
2025-06-30	$7,186,594	464,851	+5.4%	Shares	Defined	2025-11-21
2025-03-31	$6,558,470	441,054	+11.0%	Shares	Defined	2025-11-21
2024-12-31	$5,260,885	397,348	-14.4%	Shares	Defined	2025-02-14
2024-09-30	$6,598,931	464,060	+10.5%	Shares	Defined	2024-11-14
2024-06-30	$5,436,609	420,140	+5.4%	Shares	Defined	2024-11-06
2024-03-31	$5,536,259	398,579	+4.6%	Shares	Defined	2024-11-05
2023-12-31	$5,437,652	381,055	-4.9%	Shares	Defined	2024-02-14
2023-09-30	$6,198,084	400,652	-58.5%	Shares	Defined	2023-11-14
2023-06-30	$15,177,431	966,100	+126.3%	Call	Sole	2023-08-14
2023-06-30	$6,707,304	426,945	+1.8%	Shares	Defined	2023-08-14
2023-03-31	$6,911,775	419,404	+11.0%	Shares	Defined	2023-05-15
2022-12-31	$5,894,426	377,848	+1.0%	Shares	Defined	2023-02-14
2022-09-30	$4,853,551	374,214	+1.5%	Shares	Defined	2022-11-14
2022-06-30	$5,175,704	368,640	-5.6%	Shares	Defined	2022-08-15
2022-03-31	$5,592,817	390,560	+9.1%	Shares	Defined	2022-05-16
2021-12-31	$4,879,987	358,033	-8.3%	Shares	Defined	2022-02-14
2021-09-30	$6,392,520	390,264	-3.2%	Shares	Defined	2021-11-15
2021-06-30	$6,783,597	403,066	+0.1%	Shares	Defined	2021-08-16
2021-03-31	$7,354,211	402,750	+13325.0%	Shares	Defined	2021-07-20
2020-12-31	$54,600	3,000	-99.1%	Call	Defined	2021-02-16
2020-12-31	$5,823,924	319,996	-1.5%	Shares	Defined	2021-02-16
2020-09-30	$5,798,000	325,000	+3.8%	Put	Defined	2020-11-16
2020-09-30	$5,585,966	313,115	-3.7%	Shares	Defined	2020-11-16
2020-09-30	$5,798,000	325,000	0.0%	Call	Defined	2020-11-16
2020-06-30	$5,827,250	325,000	0.0%	Call	Defined	2020-08-14
2020-06-30	$5,827,250	325,000	+9.3%	Put	Defined	2020-08-14
2020-06-30	$5,331,356	297,343	-8.5%	Shares	Defined	2020-08-14
2020-03-31	$4,933,500	325,000	-19.4%	Put	Defined	2020-06-16
2020-03-31	$6,120,935	403,224	+24.1%	Shares	Defined	2020-06-16
2020-03-31	$4,933,500	325,000	—	Call	Defined	2020-06-16
No filing history on record for this holder in this stock.